Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Acoustic Separation Improves Stem Cell Transplants

By HospiMedica International staff writers
Posted on 20 Sep 2011
Transplantation of hematopoietic stem cells is an effective treatment for patients with malignant blood diseases. More...
The composition and quality of the transplanted cells are crucial to the outcome. Swedish researchers have now developed a method to improve the quality of the transplanted cells using ultrasound technology for cell separation.

For patients with blood cancer, a blood stem cell transplant is typically the only treatment that can cure the disease. The quality of the transplanted blood stem cells and the choice and composition of the transplanted cells can be crucial.

Current methods of collecting and processing stem cell products leave a lot to be desired. Recent results from Lund University indicate that it may be possible to improve significantly the quality of the blood stem cell product by using a method known as acoustic cell separation. “The method was developed in the field of microtechnology and builds on basic engineering research from Lund University,” explained Prof. Thomas Laurell, research group leader at the faculty of engineering at Lund University (Sweden). The technique is expected to facilitate improvements in the processing of blood stem cells.

Associate professor Stefan Scheding, senior consultant at the department of hematology at Skåne University Hospital and research group leader at the Stem Cell Center at Lund University, is in charge of the preclinical development of the new method, which aims to effectively separate and possibly remove or concentrate cell populations that are normally found in standard blood stem cells products. The first phase has been to demonstrate that the method works, by separating out platelets from stem cell products.

“Our hope is that it will become possible to produce the optimal stem cell product for each individual transplant patient,” said Prof. Scheding. “This would give us a good chance of improving the treatment of patients who would otherwise be at risk of suffering from serious transplant complications, such as graft-versus-host disease and infections. By optimizing the quality of the transplanted cells, it may even be possible to better fight the leukemia cells that remain in the body despite the transplant treatment.”

Related Links:

Lund University



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.